Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sequana Medical NV's share price for the quarter that ended in Jun. 2025 was $3. Sequana Medical NV's Shares Outstanding (EOP) for the quarter that ended in Jun. 2025 was 57.21 Mil. Therefore, Sequana Medical NV's market cap for the quarter that ended in Jun. 2025 was $171.63 Mil.
Sequana Medical NV's quarterly market cap
increased
from Jun. 2024 ($107.73 Mil) to Dec. 2024 ($133.31 Mil) and
increased
from Dec. 2024 ($133.31 Mil) to Jun. 2025 ($171.63 Mil).
Sequana Medical NV's annual market cap
stayed the same
from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.00 Mil) but then
increased
from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($133.31 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sequana Medical NV's Enterprise Value for Today is $93.21 Mil.
Sequana Medical NV (OTCPK:SQNMF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sequana Medical NV Market Cap Related Terms
Sequana Medical NV Market Cap Historical Data
* Premium members only.
The historical data trend for Sequana Medical NV's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Sequana Medical NV's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sequana Medical NV Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sequana Medical NV's Market Cap distribution charts can be found below:
* The bar in red indicates where Sequana Medical NV's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sequana Medical NV's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sequana Medical NV (SQNMF) has a Market Cap of $54.39 Mil as of Jul. 03, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sequana Medical NV and its competitors. According to the industry distribution chart, Sequana Medical NV ranks #529 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 60.9%.
Is Sequana Medical NV's Market Cap too high?
Sequana Medical NV's current Market Cap is $54.39 Mil. The Medical Devices & Instruments industry median Market Cap is 122.08. Sequana Medical NV's value of $54.39 Mil is 55.4% below this industry median. Based on the distribution chart, Sequana Medical NV ranks #529 out of 868 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Sequana Medical NV has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Sequana Medical NV's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sequana Medical NV ranks #529 out of 868 companies for Market Cap. This places Sequana Medical NV in the lower half of its industry. The industry median Market Cap is 122.08. Sequana Medical NV's value of $54.39 Mil is 55.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 122.08, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sequana Medical NV's current Market Cap of $54.39 Mil is 55.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sequana Medical NV and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 122.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sequana Medical NV's current Market Cap is $54.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sequana Medical NV stock overvalued right now?
Sequana Medical NV (SQNMF) has a current Market Cap of $54.39 Mil. The stock's GF Value™ is $0.48, compared to a current price of $1.22 — trading 154.2% above its estimated fair value. The current Market Cap is $54.39 Mil and 55.4% below the Medical Devices & Instruments industry median of 122.08. Sequana Medical NV's overall GF Score™ is 31/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Sequana Medical NV (SQNMF), the current Market Cap is $54.39 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sequana Medical NV (SQNMF) Overvalued in 2026?
Based on GuruFocus' analysis, Sequana Medical NV stock appears to be overvalued.
The current stock price of $1.22 is trading 154.2% above its estimated GF Value™ of $0.48.
Key valuation signals for SQNMF:
Market Cap: $54.39 Mil
GF Value™: $0.48 vs. price of $1.22 (154.2% above fair value)
Industry Position: 55.4% below the Medical Devices & Instruments median (#529 of 868)
No single metric tells the full story. See the SQNMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies. The company's geographical segments include Switzerland, Germany, the United Kingdom, France, and the Rest of the world, out of which Germany accounts for the majority of the revenue.
31GF Score
Get the complete analysis for SQNMF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SQNMF has been successfully added to your 
